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1. IntroductIon
Radiation, is an integral part of the universe functioning. 
Even, life forms are evolved in a radiation rich environment1-3. 
Radiation is a wave of energy that is made-up of streams of 
particle called photons. There are different kinds of radiation 
exists all around us like ‘visible light’ help us to visualise, 
ultraviolet radiation used for sterilisation, infrared radiation 
(heat energy used in microwave oven), sound, phone, radio 
and television signals4, etc. Basically, atom conserved energy 
that released in the form of radiation either upon atomic 
structure disintegration (fission reaction) or integration (fusion 
reaction). The common source of electromagnetic radiation 
on the earth is the nuclear fusion reaction continuing on the 
Sun where hydrogen atoms gets fused into helium and atomic 
mass difference transforming into solar radiation. Based on the 
energy carrying potential of the wave photons that can either 
excite and ionise or only excite but not ionise the atoms or 
molecules, radiation is categorised as ionising radiation and 
non ionising radiation.
Ionising radiation is described as the amount of energy 
capable to knockout the electrons from their set orbits around 
atomic nucleus resulted imposed positive charge on the atom. 
These electrically charged molecules and atoms are called ions. 
Examples of Ionising radiation includes cosmic radiation in the 
space, gamma rays used during radiotherapy of cancer patients, 
positron beam used during Positron Emission Tomography 
(PET) scanning, radioisotopes used for scintigraphy purposes, 
X rays used for human diagnostics5, Iodine-131 isotope used 
for thyroid cancer detection, phosphorus-32, and Tritium-
99 used for research purposes and nuclear radiation (alpha, 
beta particles, gamma rays and neutrons) generated from the 
nuclear reactor accidents (Chernobyl in USSR, Fukushima in 
Japan) or nuclear bomb explosion (Hiroshima and Nagasaki) 
in Japan6. Ionising radiation carries tremendous amount of 
energy that oxidise the molecules come in its path. In biological 
systems ionising radiation induces radiolysis of water and 
thus produces free radicals that further accelerate oxidation 
of other vital molecules lead to chemical and thus biological 
reactions impairment lead to cell death. Based on energy 
strength and mass of the energy particles, ionising radiation 
is further categorised as low LET and high LET radiation. 
Gamma and X-rays have maximum penetration power because 
they have less mass and high energy and thus belongs to low 
LET radiation category. On the other hand alpha, beta particles 
and neutron carries sufficiently high energy but heavy mass. 
Therefore, they cannot travel to a long distance and thus have 
low penetrating power are classified as high LET radiation. 
Gamma radiation consists of photons that originate from 
the nucleus6. While, X-ray radiation consists of photons that 
originate from outside the nucleus, and relatively have lower 
energy than gamma radiation. Photon radiation (γ and X rays 
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both) can penetrate very deeply inside the objects including 
human tissues and organs come across their path7. 
2. nAturAl sourcEs of IonIsIng 
rAdIAtIon 
Radiation is always present around us. A hypothesis1-3 
explained that how life was evolved on the earth in the 
presence of ionising radiation. Being the part of evolution, 
ionising radiation has significant effect on chemical and 
biological evolution. Many naturally occurring radioisotopes 
are primitively formed by interaction of cosmic rays with the 
molecules in the atmosphere. Tritium is an excellent example 
of a radioisotope that formed by cosmic ray’s interaction 
with atmospheric molecules. Some radioisotopes such as 
Uranium and Thorium were formed at the time of solar system 
evolution. These radioisotopes have billions of year’s half life 
and still contributing to the background radiation in the natural 
environment8. 
3. rAdIAtIon
The earth’s outer atmosphere is continually bombarded 
by cosmic radiation. Cosmic rays are ultra-high energy (range 
100-1000 TeV) radiation which originating outside the solar 
system, wide-spreading across our Milky Way galaxy and 
striking the Earth continuously from the space. Victor Hess 
discovered cosmic rays. He has observed that an electroscope 
discharged more frequently as it ascended at higher atmosphere 
with a balloon. Victor Hess has attributed this phenomenon with 
the radiation that entering the atmosphere from outer space9. 
The energy of cosmic rays is usually measured in the units of 
Mega-electron volts (MeV) or in Giga-electron volts (GeV). 
The highest energy cosmic rays measured to date had more than 
1020 eV. Intensity of cosmic radiation increases with increasing 
altitude, suggested their origin from outer space. Further, 
intensity of the cosmic rays changes with the latitude, suggested 
presence of charged particles in the cosmic rays composition 
that was affected by the earth’s magnetic field. Cosmic rays 
general composition10 is as: ~90 per cent protons (hydrogen 
nuclei), ~9 per cent alpha particles and ~1 per cent electrons. 
Cosmic rays may also have a small fraction of heavier particles 
and about ~0.25 per cent light elements like lithium, beryllium 
and boron). Cosmic rays density in the interstellar space is 
estimated to be about 10-3/m3. It has been observed that high 
energy collisions in the upper atmosphere produce cascades 
of lighter particles like Pions and Kaons. These light particles 
are further decayed and produced Muons. According to an 
estimate, Muons is contributed to more than a half of the total 
cosmic radiation. Surprisingly, presence of isotope 10Be (half-
life of 1.6 million years) in the cosmic ray, implies that, on 
an average, cosmic rays spend about 10 million years in the 
galaxy before escaping into inter-galactic space. Although, 
thousands of cosmic rays passed across our body every day, 
however, their radiation level is extremely low11. However, the 
greater intensity of cosmic rays in outer space is a potential 
threat for astronauts. 
4. tErrEstrIAl rAdIAtIon
Potassium, uranium and thorium and their decaying 
products such as radium and radon are the major contributors 
of terrestrial radiation on earth. Most of the naturally 
occurring unstable radionuclides are converting into their 
stable element by the process of continuous radioactive decay. 
Thus, the present radioactivity on the earth from Uranium-
238 remained only half as it originally was form, because 
of its 4.5 billion year half-life. Similarly, Potassium-40 (half-
life 1.25 billion years) is remaining only about 8 per cent 
of its original radioactivity. The adverse effects of actual 
diminishment (due to decay) of these isotopes on humans life 
will not be significant, because, human history is so short in 
comparison12-13.
5. MAn MAdE sourcE of rAdIAtIon 
The most common sources of man-made radiation 
exposure to the human are medical procedures, i.e. diagnostic 
X-rays, CT scanner, PET scanner, nuclear medicine, and 
radio-therapy unites. In addition, peoples are also exposed to 
radiation from consumer products containing radioactivity, 
such as tobacco products (contain thorium), smoke detectors 
(contain Americium), luminous watches (contain Tritium), 
construction materials, eye glass, televisions screens, airport 
X-ray systems, electron tubes, fluorescent tube starters, 
lantern mantles (contain thorium), etc. Peoples can also 
expose to radiation during mining and milling of uranium 
to produce nuclear energy. Radiological dispersal devices 
(RDD) can be a prominent man-made source of radiation. 
Besides these, the most significant source of nuclear radiation 
exposure to the general public is the nuclear power plant 
accidents like Chernobyl (USSR) and Fukushima (Japan). 
Finally, nuclear weapon detonation during testing or attack 
may contribute substantially to the general public radiation 
exposure14.
6. bIologIcAl dAMAgE scAlE of 
nuclEAr rAdIAtIon: InvErsE squArE 
lAw And thE rulE of sEvEn
Biological damage induced by ionising radiation depends 
on its distance from the victim and energy levels (dose 
rate). Radiation (gamma or X-ray) emission strictly obeys 
the inverse square law. According to this law, the intensity 
of radiation becomes weaker as it spreads out from the 
source over a larger geometrically uniform area. Therefore, 
in principle, the intensity of radiation will be inversely 
proportional to the square of the distance from the source. It 
is true because the surface area of a sphere increases with 
the square of the radius. It means, if a person stand twice as 
far away from the radiation source, he will receive only one-
quarter (1/4th ) of the radiation energy  as compared to the 
person stand at the point of radiation source in the equal time 
frame. Inverse square law can be understood in the nature 
by calculating the difference in intensity of solar radiation 
at different planets. The intensity of solar radiation release 
from the Sun is calculated as 9126 W/m2 at the distance 
of  Mercury (0.387 AU), whereas, it is only 1367 W/m2 at 
the distance of Earth (1 AU). Therefore, it suggested that 
approximately three fold increase in the distance leading to 
nine fold decrease in the solar radiation intensity15-16.
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7. rAdIAtIon ExPosurE by AtoMIc 
wEAPon ExPlosIon
The energy emitted during nuclear explosion is the result 
of the splitting of atomic nucleus and subsequent chain reaction 
of radioactive materials, i.e. Uranium-235 and Plutonium-239 
nucleus. The energy that released from an atomic explosion 
can be quantified in terms of kilotons (Kt) of the conventional 
explosive trinitrotoluene (TNT). The energy composition of 
nuclear explosion can be divided into fireball (thermal and 
radiation energy), blast forces/waves (high energy shock 
wave), prompt/early radiation (gamma rays) wave, light energy, 
and  delayed ionising radiation that is produced by the fallout 
of the radionuclides generated during nuclear fission chain 
reaction17. The prompt/early radiation pulse predominantly 
gamma rays and neutron generates within milliseconds of 
detonation can cause whole body exposure and acute radiation 
syndrome (ARS). Atomic fission reaction is produced a mixture 
of about ~80 different radionuclides. These radionuclides 
are varied in terms of their stability. Some nuclides are 
completely stable while, others unstable and thus undergo 
radioactive decay with half-life’s range from fractions of 
a second (short lives isotopes) to thousands of years (long 
lived isotopes). About >300 different isotopes belong to 
approximately 36 different elements have been identified in 
the mixture of fission reaction products. As far as concerned 
with the radiation effect, thumb rule is the ‘rule of sevens’. 
This rule is explained that every seven-fold increase in the 
time followed by a nuclear detonation, the radiation intensity 
(dose) decreases by the factor of 10. For example, after 7 h 
of explosion, the residual radioactivity will be declined by 90 
per cent. Further, it will decline again by 90 per cent after 
7x7 h (49h, approximately 2 days). The radiation level will 
drop again by 90 per cent after 7x2 days (2 weeks). The rule 
of seven is accurate to 25 per cent for the first two weeks, 
and it is accurate to a factor of two for the first six months. 
After 6 months, the rate of radiation decline becomes much 
more fast. The radioisotopes fallout can contaminate soil, 
food and water supply of the surrounding area. Radiation from 
contaminated area can induce structural and functional damage 
to the biological system. Though, outcome of the biological 
radiation injuries depends on radiosensitivity of the involving 
system/organs. Radiosensitive systems like hematopoietic and 
gastro-intestinal system are considered more radiosensitive as 
compared to skin, muscular, and nervous system. Following 
are dose dependent biological effects of whole body gamma 
irradiation on human organ systems18-20.
8. rElEvAncE And IMPortAncE of 
rAdIoProtEctor dEvEloPMEnt 
A study published by Coeytaux21 to estimate radiation 
accidents worldwide within the period of 1980 to 2013, revealed 
that total 634 radiation accidents were reported during the 
years of 1980-2009, that involves 2390 overexposed peoples, 
out of whom 190 people died due to radiation lethal dose over 
exposure. This study further stated that though number of 
radiation accidents is decreased for all types of radiation use, 
but increases in the medical sector (64 per cent) particularly 
radiotherapy and fluoroscopy procedures. 
Radiation countermeasures are extremely useful for 
military personnel and first responders in case of nuclear 
emergency. Medical management of nuclear accident is 
the most significant area where radiation countermeasure 
unavoidably applicable. The industrial sector contributes 
about 24 per cent of total worldwide reported radiation 
accidents21. India is expanding its nuclear energy needs 
and thus Indian federal government committed to increase 
nuclear installations. Former Indian President Late 
(Dr) A.P.J. Abdul Kalam, has stated while he was in the office, 
that ‘The energy independence is India’s first and highest 
priority milestone need to achieve as soon as possible” and 
therefore India has to go for nuclear power generation in a 
big way using thorium-based reactors’. Indian government 
has ambitious plan to increase the contribution of nuclear 
power to expedite its electricity generation capacity from 2.8 
per cent to 9 per cent within next 25 years. In view of that, 
the Indian nuclear power industry is expected to undergo an 
unprecedented expansion in the coming years. To achieve 
ambitious milestones of nuclear power generation, Indian 
government passed U.S.-India Civil Nuclear Agreement to 
carry out trade of nuclear fuel and technologies with other 
countries to enhance its power generation capacity. When 
this agreement implemented, India is expected to generate 
an additional 25,000 MW of nuclear power by the year of 
2020, bringing total estimated nuclear power generation to 
45,000 MW. In view of government planning to enhance 
nuclear power generation capacity, nuclear power reactor 
installations are bound to increase in future. Though, extreme 
safety measures are implemented for nuclear power plant 
safety, however still nuclear reactor incidents or accidents 
(level 1-7 level) cannot be ruled out completely. Available 
substantial evidences of level 7 nuclear reactor accidents 
in the past like Chernobyl in Ukraine (formerly USSR) and 
Fukushima in Japan are enough to understand the significance 
of radiation countermeasures for civilian as well as for 
defence sector. 
Among the radiation accidents occurred worldwide since 
1980-2013, most of them belong to medical procedures, either 
during radiation therapy (32 per cent) or fluoroscopy (31 per 
cent). According to the number of overexposed persons, 
reported accidents involving radiation therapy were greater 
(47 per cent), followed by accidents in the industrial sector 
(22 per cent), then in fluoroscopy (17 per cent) and orphan 
sources (9 per cent). Interestingly, the published report21 
demonstrated that though, radiation accidents and the number 
of exposed persons are declined significantly in all sectors 
dealing with radiation in the last three decades (1980-2009) 
except in medical sector (i.e. radiatiotherpay and medical 
fluoroscopy). Geographical distribution is demonstrated 
that medical sector accounted for maximum radiation 
overexposures in North America (663 cases, 91 per cent), 
Europe (642 cases, 93 per cent), and South America (163 
cases, 61 per cent) 21. Due to increasing cancer accidents, uses 
of radiation therapy are expected to increase in the future. 
Therefore, it is crucial to ensure high quality assurance error 
proved standard procedure to avoid over exposure accidents 
in radiotherapy patients. 
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8.1 Estimated radiation dose vs radiation 
Accidents
8.1.1 Chernobyl Radiation Accident
The Chernobyl nuclear reactor accident occurred in the 
very early morning of 26th April 1986 in USSR. It was the 
most serious accident in the history of the nuclear industry. 
It occurred due to meltdown of reactor core and subsequent 
explosion and fire. Cloud of various types of radioactive 
materials, especially iodine-131 and caesium-137 was spread 
over the Europe including Belarus and the Russian Federation. 
Radiation Workers who were operating near the reactor at the 
time of the accident exposed with high doses of gamma radiation 
(i.e. 2 - 20 Gy). Evacuated population from the accident 
area was exposed to an average radiation dose of ~33 mSv. 
However, some individuals were exposed to several hundred 
mSv of radiation doses. Through consuming contaminated 
food containing radioactive iodine-131, some people received 
very high internal doses of radiation (up to 50 Gy), particularly 
in the thyroid gland. Out of 134 emergency radiation workers 
who received high doses of radiation were diagnosed with 
acute radiation syndrome (ARS) and 28 of them died within 
a month after the accident. Chernobyl radiation accidents 
accounted 56 direct deaths (47 radiation workers + 9 children 
with thyroid cancer). However, the general population exposed 
to the Chernobyl fallout not suffers from ARS, as the radiation 
doses received by them were relatively low22-24.
8.1.2 Fukushima Radiation Accident
Followed by a major earthquake in Japan on 11 March 
2011, huge tsunami waves disrupted the power supply and 
cooling system of three Fukushima Daiichi reactors, causing 
devastating nuclear accident. The accident was rated of 7th 
level on the INES scale, due to high radioactivity releases (940 
PBq of Iodine-131 eq). Though, there were no deaths reported 
due to radiation sickness, but over 100,000 people evacuated 
from their homes to ensure their safety. TEPCO had estimated 
the radiation exposure of 19,594 people who worked on the 
accident site. According to the reports, 167 workers exposed 
with radiation. Out of these 135 workers had received 100 
to 150 mSv, 23 workers received 150-200 mSv. While, three 
workers received 200-250 mSv, and last six workers received 
over 250 mSv (309 to 678 mSv) apparently due to inhaling 
Iodine-131 fume. The highest dose rate at the site of accidents 
was estimated to be 300 mSv/h. Though, higher than normal 
doses were accumulated in hundreds of workers deployed on 
the accident site, but no radiation casualties (acute radiation 
syndrome) reported 25-28. 
8.1.3 Tokaimura Radiation Accident 
Tokai-mura accident (1999) occurred in a very small fuel 
preparation plant operated by Japan Nuclear Fuel Conversion 
Co. On 30th September morning, three workers initiated a 
preparation for a small batch of fuel for experimental purpose 
using enriched (18.8% U-235) uranium. Eventually, volume 
of reaction reached at about 40 litres containing about 16 kg 
Uranium. As critical mass achieved, nuclear fission chain 
reaction was initiated with intense gamma and neutron 
radiation emission. Doses assessment analysis revealed that 
three worker involved in that experiment received whole body 
radiation doses of 16-20,000 millisieverts (person-1), 6-10,000 
millisieverts (Person 2) and 1-5000 millisieverts (person 3)), 
mainly from neutrons and died within 12 week. Absorbed dose 
for other 436 people was evaluated, none of them exceeded 50 
mSv (the maximum allowable annual dose)29-31. 
8.1.4 Soviet Submarine K-431Radiation Accident 
Soviet submarine K-431, a Soviet nuclear-
powered submarine was commissioned on September 30th, 
1965. An explosion occurred in this submarine during 
refueling at Chazhma Bay, Vladivostok.  Total 10 causalities 
(8 officers+2 assistant) were reported in the accidents due to 
explosion rather radiation exposure. However, other 49 people 
received radiation injuries with 10 people developed radiation 
sickness (mostly fire-fighter). Some people exposed with 2.2 Gy 
external dose and 4 Gy internal dose to thyroid gland. Besides 
that, out of 2000 persons involved in cleanup operations, 290 
received high level of radiation dose compared to normal set 
limit32. TIME magazine reported this accident as one of the 
world’s ‘worst nuclear disasters’.
8.1.5 Soviet Submarine K-27 Radiation Accident
On May 24th 1968, the power output of one reactor of 
submarine K-27 suddenly dropped and radioactive gases were 
released and accumulated into its engine cabin. The radiation 
(compositions: mainly gamma rays and thermal neutrons with 
alpha and beta particles) level were increased dangerously by 
1.5 Gy/h. Total 9 causalities were reported due to k-27 radiation 
accidents33.
8.1.6 Soviet Submarine K-19 Radiation Accident
On July 4th 1961, soviet submarine K-19 was 
conducting naval exercises in the North Atlantic close to 
Southern  Greenland under the command of Captain Nikolai 
Vladimirovich Zateyev. Suddenly, a substantial leakage 
in its nuclear reactor’s coolant system was observed. The 
submarine reactor temperature increased upto 800 °C 
due to heat generated by fission reaction. The submarine 
reactor continued to heat up as the required coolant was not 
available. Captain Zateyev ordered the team of engineers on 
board to fabricate a new coolant system via removing off an 
air vent valve and jointing a water-supplying pipe into it. 
This procedure need to work the engineers in high radiation 
environment for extended periods. As air vent valve removed 
the radioactive steam containing fission products spread into 
ventilation system and other compartments of the submarine. 
However, this procedure successfully reduced the core reactor 
temperature but all seven members of the engineering crew 
and one divisional officer on board exposed with lethal doses 
(11-54 Gy) of radiation and all died within a month. Besides 
that, 15 other sailors exposed with relatively low doses of 
radiation and all died within next two years34-35. 
8.2 the goiânia radiation contamination Accident 
due to stolen radiation source 
On September 13th 1987, at Goiânia, in the Brazilian state 
of  Goiás, an old  radiotherapy source was stolen from the 
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city hospital and subsequently handled by many people in the 
scrapyard resulted four causality as: 
Leide das Neves Ferreira, six year old daughter of Devair • 
Ferreira the scrapyard owner was the first death out of 
four people exposed with stolen radioactive source. She 
received 6.5 Gy whole body radiation. 
Gabriela Maria Ferreira, 37 year old wife of Devair • 
Ferreira, became sick about three days after coming in 
contact with the radioactive source. She received 5.7 Gy 
dose of radiation and died. 
Israel Baptista dos Santos• , 22 year old employee of Mr. 
Ferreira who worked on the radioactive source primarily 
to extract the lead was exposed with 4.5 Gy of radiation 
and died. 
Admilson Alves de Souza• ; 18 years old another employ 
of Mr. Ferreira exposed with 5.3 Gy dose of radiation 
and died. However, surprisingly, Devair Ferreira himself 
was survived despite receiving 7 Gy of radiation. He died 
later on in 1994 due to cirrhosis aggravated by depression 
and binge drinking36-37.
8.3 cecil Kelley criticality radiation Accident at 
los Alamos
Cecil  Kelley  was  a  chemical  plant operator and operating 
a large (1,000 liter capacity) stainless steel plutonium mixing 
tank. The tank contained residual plutonium-239 remained 
unutilised from other experiments. Suddenly plutonium in the 
tank achieved criticality and incursion with flash bright 
light was emitted. The Kelley stand near by the tank was 
completely showered with the excursion mixture and 
heavily exposed with fast neutron (9 Gy) and gamma ray 
(27 Gy), total 36 Gy. Though Kelley received immediate 
medical support but he lost his life within 35 h after the 
radiation incident occurred38-39. 
8.4 nuclear weapon detonation vs radiation 
doses: A real Experience
The only factual experience in the history of nuclear 
attacks is preserved with the Hiroshima and Nagashaki, 
Japan nuclear attack by US army in 1945. Hiroshima was 
blown up by Uranium bomb (based on fission principle) 
named “little boy” (reported yield; 16 KT), while 
Nagashaki was bombarded by plutonium bomb (based 
on fusion principle) named ‘fat man’ (reported yield: 21 
KT). Hiroshima bomb was exploded at 600 m height from 
the ground. The bomb energy distribution was estimated 
to be as: 50% of total bomb energy was converted in to 
blast wave, 35% energy converted in to heat wave and 
15% energy converted into radiation (10% residual + 5% 
instant radiation). A relationship between initial radiation 
reached to the hypocenter (ground zero) in Hiroshima 
versus distance from the ground zero was placed below 
(Figs. 1 and 2). Ionising radiation in the form of neutrons 
and gamma rays generated from the nuclear fission 
chain reactions was reached at ground zero even prior 
to the explosion occurred and affect the human body40. 
People received lethal dose of pre neutron and gamma 
radiation at this point died, regardless of the high pressure 
shock and heat waves. Various people who were involved 
in vigorous rescue operation at around 1,000 m to 1,500 m 
away from ground zero not experienced radiation sickness 
immediately but they suffered due to an estimated exposure 
radiation of 1,500 mSv to 2,500 mSv dose (Figs. 1 and 2). 
8.5 residual radiation in hiroshima after nuclear 
blast
Residual radiation classified in to two categories, i). 
Induced radiation (activated neutron reached to ground, 
and ii). Radiation from radioactive fallout of more than 300 
radioisotopes. Induced radiation produced by the collision 
of ground reaching neutrons with other materials that create 
radionuclide. The amount of nuclides generated depends on the 
amount of neutrons that reach the ground. The radiation dose 
versus distance relationship of Hiroshima induced radiation is 
given in (Figs. 1 and 2). Persons remained for 100 h within 
1 km of ground zero following the blast may expose one to 
several sieverts of radiation. Induced radiation decays to 1/100 
after 30 min, 1/1000 after one day, and 1/1,000,000 after a 
week.
Residual radiation composed of radioactive products 
produced from the fission reactions blowned- up into the 
mushroom cloud. Due to their high mass radioactive nuclides 
come down in the form of black rain. The black rain contained 
several thousands of isotopes including of uranium 235 and 
plutonium 239 (half-life of 25,000 years) that did not undergo 
figure 1. neutron radiation dose along with distance from the hypocenter 
of hiroshima nuclear attack.
figure 2. gamma radiation dose along with distance from the hypocenter 
of hiroshima nuclear attack.
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fission reaction and prominent source of alpha emission that 
damage the biological systems of the personals engaged with 
cleanup operation40-41. 
9. vIrtuAl coMPutEr sIMulAtIon 
AnAlysIs of nuclEAr wEAPon 
dEtonAtIon vs rAdIAtIon dosE In thE 
EnvIronMEnt
Software based simulation42 predicted the possible 
nuclear weapon devastating effect in terms of nuclear radiation 
yield, thermal radiation and blast/shock wave strength along 
with increasing time and distance variables. Data of the 45KT 
yield nuclear bomb detonation computer based simulation 
was predicted maximum radiation dose (neutron+gamma 
ray+alha+beta) to be 50 Gy within the radius of 1.14 km. 
However, with increasing distance, radiation dose will be 
reduced as it will be 10 Gy at 1.46 km radius, 6 Gy at 1.57 
kn radius and 5 Gy at 1.61 km radius. Though, radiation 
dose will be 10 Gy in the radius of 1.46 km however, 
thermal radiation produce fire storm within this radius, 
therefore, everything come in contact with firestorm will 
be meltdown. Therefore, medical intervention cannot be a 
viable option in the short hypocenter area. Further, 7 km 
- 8 km distance from the hypocenter will have 5-6 Gy of 
radiation, however, third degree burns will be the main 
culprit of instant deaths. Therefore, more causality will 
occur due to heat burns as compared to radiation injuries. 
Instead of initial first cycle of radiation, residual radiation 
due to radionuclide’s fallout will be the major concerned for 
evacuation workers. Fallout contour (Fig. 4) demonstrated 
~10 Gy/h radiation dose due to fallout within the area of 
15.6 km2 with maximum stem of 1.37 km. The radiation 
level will be about 1 Gy/h at maximum downwind cloud 
distance of 39.8 km with maximum width of 2.83 km. The 
total affected area will be about 200 km. Similarly, the 
radiation level in the next 83.9 km will be 0.1 Gy/h with 
maximum width of 7.63 km. The approximately affected 
area of 0.1 Gy/h radiation dose will be approximately 729 
km2. Further calculation revealed that total area affected 
with low radiation level equal to 0.01 Gy will be 2580 km2. 
Considering the simulated data for possible interventions 
of medical countermeasure is only applicable in the fallout 
area having high radiation background (0.1 Gy/h to 10 
Gy/h) without sufficient heat radiation42. However, in real 
scenario combined (radiation with heat) injuries will be 
the real threat. Therefore, strategies to manage combined 
radiation injuries need to be developed. 
10. bIologIcAl rAdIoProtEctor 
dEvEloPMEnt 
In view of above mentioned planned or unplanned 
radiation incidents/accidents, development of 
radioprotective agents is considered as an urgent 
requirement. Since 1945, several radiation countermeasure 
agents from natural and synthetic origins are evaluated for 
their efficacy, toxicity and utility. Based on the technical 
knowledge and scenario of applications, radiation 
countermeasures are classified into three main categories 
i.e. radioprotectors, radiomitigators and radiation-therapeutics. 
Radioprotectors are agents which administered before 
radiation exposure to protect the radiation damage. Radiation 
mitigators are the compounds that administered shortly after 
radiation exposure but before radiation exposure symptoms 
manifested. While, radiation-therapeutics are classified as 
the agents which given after ARS symptoms appeared. These 
agents basically acts to stimulate repair or regeneration in 
the damage biological system. To develop excellent, ideal 
radiation countermeasure agents, various idealistic properties 
were primarily proposed by the investigators from AFRI, USA 
and now followed to test the efficacy, toxicity and applicability 
of the radioprotective agents in different emergency scenario 
at global scale. Some of the ideal consensus parameters for 
radioprotector development are as follows:
A radiation countermeasure agent should provide • 
multifaceted protection to all biological systems against 
lethal doses of ionising radiation despite different 
figure 3. Acute radiation syndrome vs radiation dose and death 
percentage.
figure 4. computer based simulation of nuclear weapon (yield 45Kt) 
detonation and level of nuclear (instant and fallout radiation) 
and heat radiation with increasing distance. 
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sensitivity of different organs against radiation damage!!.
A radioprotective agent should have nearly same efficacy • 
for different types of radiation (X-ray, gamma ray, 
neutrons) and dose rate!.
An agent that can provide extended protection over several • 
days and can reduce effect of radiation by the factor of 2 
(DRF 2.0 or more) without appearing toxic effects.
An agent should not have cumulative effect if required • 
repeated administration (for mitigator or therapeutic class 
of radiation countermeasure).
An agent should have no/minimal adverse effects and • 
toxicity on physiology and organ functions of treated 
subjects. 
An agent should have large effective time and dose window • 
with extended stability profile.
The agent should be compatible with the wide range • 
of supportive care agents and drugs like antibiotics, 
immunotherapeutics etc.
A radioprotective agent should have sufficiently long shelf • 
life and economical viability.
A radioprotector for emergency, should be effective in • 
bear minimum time period (<30 min) and its effectiveness 
should be maintained for longer durations (>6 h). 
A radioprotective agent should have differential protection • 
in normal and tumour cells/tissue, so that it can be used 
during normal radiotherapy. A radioprotective agent 
should be useful in combined radiation injuries 
scenario if possible. 
Despite all serious attempts for radiation 
countermeasure development, till date not a single agent was 
qualified on all outstanding parameters advised to consider 
during the course of developmental stages. A number of 
radiation countermeasures (specifically radioprotectants 
and radiomitigators) have been identified and at various 
stages of US FDA approval (Table 2).
11. nAtIonAl And IntErnAtIonAl 
stAtus of rAdIAtIon 
countErMEAsurE
Several chemical compounds of synthetic and natural 
origins have been tested for their radioprotective activity 
after world war II. In 1959, U.S. Army initiated a program 
at Walter Reed Institute to identify and synthesise drugs 
molecules capable of protecting individuals from gamma 
radiation. They synthesis approximately 4000 chemical 
compounds and tested their radioprotective efficacy. 
Among 4000 compounds screened, only amifostine 
(WR2721) was selected and further evaluated for its 
toxicity. This compound is still under clinical trial phase-III 
for neck and head cancer radiotherapy patient’s normal tissue 
protection. However, due to its neurotoxicity i.e. nausea and 
vomiting it was not qualified for nuclear accidents medical 
management for general public. Since from 1959, hundreds 
of chemical and natural compounds have been evaluated 
for their radioprotective activities in USA and other parts of 
world including Europe and Russia. However, US scientists 
have taken lead in radiation countermeasure development43-45 
resulted eight molecules have been granted IND status 
and another four are under advance stage of development as 
shown in Fig. 5.
In India two main Centres i.e BARC Mumbai and INMAS, 
Delhi have initiated radiatioprotector development work 
almost two decades before and evaluated several molecules 
for their radioprotective activities. Particularly, INMAS took 
the lead in radiation countermeasure development programme 
and evaluated Indian herbs as the prominent sources of 
radioprotective molecules. Podophyllum hexandrum, 
Hippophae rhamnoides, Rhodulla embricata and Tinospora 
cordifolia was evaluated for their radioprotective efficacy 46-52. 
Apart from that radioprotective efficacy of pure molecules 
isolated from Podophyllum hexandrum was established at 
INMAS53. Study on pdophyllum hexandrum’s pure molecules 
is progressing towards higher animal efficacy and toxicity 
studies using NHP model. Another novel approach using 
radioresistant bacteria as prominent source of radioprotective 
molecules was undertaken at INMAS. A secondary metabolites 
of radioresistant bacterium Bacillus sp. INM-1 was isolated, 
characterised and evaluated for radioprotective activity 
in lower animal model54-60. The study is progressing well 
towards formulation development and toxicity evaluation. 
Besides INMAS, other Indian investigators also evaluated 
several Indian herbs for their possible radioprotective efficacy 
as shown in Table 1.
figure 5. radiation countermeasure in advance stage of development 
in usA.
12.  concIsE roAdMAP of rAdIAtIon 
countErMEAsurE dEvEloPMEnt
Though, Drug Controller General of India (DCGI) do not 
have any specific guidelines under “Drug and Cosmetic Act 
of India” to evaluate and approve radiation countermeasures 
for clinical and emergency uses. However US-FDA formulated 
guidelines to evaluate and approve a radiation countermeasure 
for clinical testing. The radiation countermeasure development 
process was categorised in two parts i.e. i). Preliminary 
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table 1. radioprotective agents under investigation in usA/russia and in India42-45,46-60
screening and selection of lead radioprotective compounds 
and II). Translational studies including preclinical and clinical 
aspects. Due to lack of consensus on common molecular target 
of radioprotection, no high throughput methods for screening 
of radioprotective agents are available. Ionising radiation 
induced free radicals in the biological system, therefore, free 
radicals scavenging potential of an agent considered as an 
integral part of its preliminary selection. Although, possessing 
antioxidant activity is not the sole criteria to select the lead 
compounds for radioprotection purpose. Several excellent 
antioxidant molecules like tampol, trolox, ascorbic acid, 
quercetin, lycopene etc. do not provide desirable in vivo whole 
body radioprotection and therefore discarded from the list of 
potential radioprotectors. Radiation exposure induced damage 
to bio-macromolecules i.e. DNA, protein and enzymes and thus 
impaired their functional integrity lead to cell death. Therefore, 
radioprotection to DNA, proteins and enzymes may be good 
criteria for radioprotector screening. Based on the outcome of 
in vitro and ex-vivo preliminary studies, selected compounds 
can be subjected to in vitro radioprotection assays using human 
or animal cells in culture. If selected agent provides desirable 
radioprotection against lethal/sub-lethal doses of gamma 
radiation to the cells in culture, the same can be subjected 
for whole body survival assay using lethally irradiated mice. 
Actually, whole body survival offered by radioprotective agent 
to the lethally irradiated mice is the gold standard for final 
selection of a radioprotective compound for further studies. If 
an agent is qualified in vivo radioprotection scale, than systemic 
level radioprotection studies need to be started. Systemic level 
radioprotection study comprises histological and biochemical 
and molecular analysis of vital organs. Based on the outcome 
of the preliminary studies, second phase i.e. translational phase 
need to be started. Drug’s pharmacological target identification 
and validation are an integral part of second phase study. The next 
step of radiation countermeasure development as suggested by 
US-FDA is toxicological and safety pharmacological profiling 
of the drug candidate in GLP certified laboratory. If drug 
candidate qualify on toxicological and safety pharmacological 
parameters, it will be ready for higher animal (preferably 
non-human primate) testing. However, before initiating NHP 
studies, it is mandatory to develop a standardised formulation 
intended to be use in human trials. Further, due to ethical 
prohibition to irradiate human during clinical trials, US-FDA 
suggested to develop an efficacy biomarker specific to the 
drug’s molecular action. The efficacy biomarker may correlate 
the animal efficacy dose corresponding to similar efficacy in 
human even without exposing the human subjects to gamma 
radiation. Followed by completion of non-human primate 
efficacy and toxicity studies with no or manageable adverse 
indications, radiation countermeasure agent will be ready for 
human clinical safety trial61. The whole procedure is highly 
expensive, time consuming and full of risks. The complete 
summarised schematic flowchart depicting all steps of radiation 
countermeasure development along with time scale is as given 
in Fig. 6. 
13. sIgnAturE IssuEs, tEchnIcAl gAPs 
And coMPlExIty In rAdIAtIon 
countErMEAsurE dEvEloPMEnt
The area of radiation countermeasure development is full 
of challenges and technical complexities. Several issues which 
significantly affect the mortality and morbidity of radiation 
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Excellence tried to achieve bottlenecks to achieve excellence strategically applicable and Practically Achievable 
radioprotection (sAPArA)
A single radiation 
countermeasure agent that 
can be use for prophylactic, 
mitigative and therapeutic 
applications.
Difficult to achieve Separate agent for radioprotection, mitigation and 
therapeutic applications should be developed.
A single radiation 
countermeasure agent for 
whole body protection
Protection efficacy of a radiation countermeasure will 
be differing with different types of radiation due to 
different RBE of different radiation types.
Separate agent should be developed for low LET and 
High LET radiation.
An efficacious radiation 
countermeasure against 
lethal dose of radiation
Efficacy level of a radiation countermeasure cannot 
be uniform in different subjects. Like, efficacy may be 
varied in male to female, young to adult and children 
to old age persons. 
Though, lethal exposure is real but a rare threat while, 
sub-lethal and below sub-lethal irradiation exposure is 
equally fatal. Thus, sub-lethal radiation exposure should 
be considered potential threat for civil population.  
Radiation countermeasure 
to manage nuclear reactor 
accidents
The maximum radiation dose in the surrounding area 
of world worst nuclear accidents i.e. Chernobyl  and 
Fukushima (level 7) was observed to be in the order 
of 100-678 mSv for public. Interestingly, 500 mSv 
is the international allowable short-term dose for 
emergency workers. 
However, in both accidents, the reactor employees 
who were working in the vicinity of the reactor, 
exposed to whole body 2-20 Gy dose of mixed 
radiation and died within weeks.
Though no specific radiation countermeasure 
intervention will be required to the general public who 
exposed less than 500 mSv dose of radiation. However, 
radiation worker exposed with high dose (2-20 Gy) of 
radiation definitely required radiation countermeasure 
(mitigator/therapeutics) with supportive care including 
antibiotics and immuno-stimulants.  




The dose of nuclear radiation during Hiroshima 
and Nagasaki atomic attack was very high 
(neutron+gamma) at hypocenter but reduced 
significantly beyond the 1000 m. Interestingly, due 
to extreme heat radiation within 1000 m everything 
was meltdown. So, no physical, chemical, biological 
or medical intervention will be helpful within 1000m 
hypocenter radius. 
Beyond the 1000 m distance, radio mitigators 
and radiotherapeutic will be required.  Further, 
medical management of radiation combined injuries 
(Radiation+heat burns+shock wave injuries) should be 
the prime concerned to manage the atomic attack.
Radiation countermeasure 
to handle nuclear fallout and 
secondary radiation after 
nuclear accident or bomb 
detonation
Past nuclear accidents suggested that Iodine-131 is 
the major threat (half life 8h) which release in gaseous 
phase and accumulated in the thyroid gland of animals 
and human and caused localized radiation damage.
Cleanup operation in the contaminated area will be 
initiated after proper monitoring of the radiation level. 
The radiation level will be reduced substantially in the 
contaminated area with increasing time and distance. So 
a radio protective drug able to protect even sub-lethal 
doses of gamma/neutron radiation may be useful.
Applications and 
significance of radiation 
countermeasure for high 
doses  (>6-50 Gy) of 
radiation
The high dose radiation exposure possibilities 
lies with  the uranium enrichment plant incidents, 
overexposure during radiotherapy, nuclear submarine 
accidents and occupational workers directly engaged 
with the nuclear reactor accident (>6 level). 
High dose radiation exposure scenario only allows the 
application of radiation mitigators and therapeutics to 
manage the ARS in radiation victims.
Radiation countermeasure 
for human-space mission in 
future
NASA’s curiosity mission was calculated the total 
galactic radiation absorbed during 360 days return trip 
to the MARS i.e. 662+/108  mSv. 
662+/108 mSv exposure is far below from the upper 
limits of accepted dose for an astronaut career. 
European, Russian, and Canadian Space Agencies 
were decided exposed radiation dose limit upto 1000 
mSv for astronaut. While, NASA limits are between 
600-1200 mSv. Therefore, radioprotective drug able to 
neutralize at least 1000 mSv (1Gy) radiation effect will 
be sufficient for future MARS men exploration. Though 
radiomitigators and radiotherapeutic agents may also be 
useful for MARS colonizers. 
table 2. Excellence vs practical consideration for radiation countermeasure development
exposure are still not answered technically. Some of them are 
discussed as follows:
Radiation effects on biological systems depend on the • 
radiation source strength (dose rate) and total absorbed dose 
in particular system/organ. The radioprotective efficacy of 
radiation countermeasure agent deviates significantly with 
changing radiation dose rate. Therefore, radioprotective 
efficacy of a radioprotector may differ with different dose 
rate. There is no standard way to fix this issue. However, 
0.6Gy/min radiation dose rate was considered optimum 
at AFRRI to evaluate radioprotective efficacy of a drug 
molecule. 
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Nuclear emergency situation involved mixed radiation • 
threat. Different types of radiation have different energy 
strength and therefore varied biological damage. Mixed 
radiation environment includes neutron, gamma rays, 
alpha particles, beta particles, fission product, heavy 
nuclei, muons, protons and charged ions. According 
to ICRP report, Radiation weighting factors WR i.e. 
Relative biological effectiveness (RBE) is substantially 
differs with different types of radiation. For examples, 
X-rays, gamma rays, beta particles, muons have WR 
equal to 1. Neutron radiation (< 1-50Mev) have WR 2.5-
5.0, protons and charged pions have WR 2, while, alpha 
particles, nuclear fission products and heavy nuclei have 
WR of 20. Due to wide variation in WR, radioprotective 
efficacy of a radiation countermeasure may not be equal 
for all radiation types.
Different organs of the body have variable radiosensitivity. • 
Immune system is more radiosensitive while CNS does 
not. Therefore, radiation doses which do not induced 
significant damage to skin, muscles and CNS, may be fatal 
for bone marrow, GI system and eyes. Therefore, common 
drug may not protect all biological systems against 
radiation damage. Unavailability of high-throughput 
method for human radio-biodosimetry and triage further 
complicate the medical management of ARS in radiation 
exposed personals. 
Despite several efforts worldwide, there is no specific • 
biochemical radiation biomarker was identified that can 
be used to evaluate radioprotective efficacy of radiation 
countermeasure agents. 
Complex nature of combined radiation injuries • 
(radiation+heat burns+traumatic shock wave damage) will 
be the real scenario in case of nuclear eventuality. However, 
no specific experimental animal model is available that 
can be used to evaluate radiation countermeasure efficacy 
against combine radiation injuries. 
14. rEcoMMEndAtIons
Lack of specific cellular or molecular targets, 
unacceptable toxicity of countermeasure agents at 
efficacious dose, less effectiveness of the agents against 
different types of radiation, less interest of pharmaceutical 
industries in radiation countermeasure development and 
unclear regulatory guidelines complicate the radiation 
countermeasure development programme. Despite several 
problems, investigators are still working to develop radiation 
countermeasure worldwide. Keeping the entire variable in 
consideration following recommendations are being suggested 
to expedite the ‘strategically applicable and Practically 
Achievable Radioprotection (SAPARA) principle: 
Definition of excellence should be modified according • 
to the applicability of radiation countermeasure. So that 
unrealistic hurdles can be avoided.
Strategic requirements and usable scenario of radiation • 
countermeasure should be clearly defined (Table 3). 
Radiation dose of 5-6 Gy is considered lethal for human. • 
However, probability of general public exposure to that 
much of high dose of radiation is very rare. Even during 
nuclear accidents and nuclear attack in Japan, general 
population inhabited at the distance >1.5 km2 do not 
figure 6. A roadmap to develop radiation countermeasure for human applications.
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expose with even sub-lethal doses of gamma or neutron 
radiation. Therefore, radiation countermeasure for 
general public protection during emergency situation is 
more than sufficient if it can effective against sub-lethal 
(2-3 Gy) doses of gamma/neutron radiation.
Combined radiation injuries will be the real scenario during • 
nuclear explosion. Therefore, a radiation counter measure 
able to help in recovery from heat burns and shock trauma 
will certainly be an ideal agent.
Several nuclear submarine accidents have been documented • 
in the past. The submarine contingent operates in close 
proximity of nuclear reactor on board. Thus, chances 
of radiation exposure are very high in case of nuclear 
submarine. Therefore, fast acting radioprotective (low 
time window), mitigative agent able to protect from 
lethal to supra lethal (5-10 Gy) doses of mixed radiation 
(gamma+neutron) will be necessary for submarine 
contingent. 
radiation accidents radioprotector radiation mitigators radiation therapeutics
nuclear reactor accidents (> level 7)
Workers operating at the site of 
accident
X
Radiation dose: > 10 Gy at the core 
of the reactor 
 










Cleanup operation   
nuclear attack (45 Kt yield)
Detonation hypocenter and 
surrounded radius of about 4-6 
km2
X
10-50 Gy but heat radiation burn 
everything
X X 
Radiation dose within 7-8 km2 
radius ( dose 5-6 Gy)
X
Instant exposure so no time for 
radioprotector  action

With 3rd degree burns (combined radiation 
injuries management

With 3rd degree burns 
(combined radiation 
injuries  management
Fallout in approximately  
2580 km2 area

Radiation dose: 0.01 to 1 Gy/h
 
Iodine-131 accumulation in 







Contamination cleanup activity   
radiation accidents in Military sector like nuclear submarine accidents
Nuclear sub-marine accidents
Radiation dose: 5-10 or more 
radiation)

Low time window agents

Agent able to protect gamma+Neutron 
radiation

Uranium enrichment and 
uncontrolled criticality reaching 
accidents
X
20-30 Gy instant exposure

Agents able to protect combined  
radiation injuries
(Radiation +3rd degree heat burns 

Immuno-modulatory 
agent to regenerate 
immune system
Medical sector radiation overexposure 
Over radiation exposure during 
Radiotherapy and fluoroscopy

Very much applicable to protect 
normal tissue from radiation damage.

Can be used in case of over radiation 
exposure due to miscalculated radiation 
dose delivery (human or machine error) 

Can be used during 
recovery period 
radiation incident due to dismantling of radiation source in scrapyard
Several incidents have been 
reported at global scale in 
which peoples exposed with 
lethal radiation doses during 
dismantling of old irradiators
X
Due to involvement of unskilled 
labourer in the dismantling work, no 
prior information will be dissipated 
for probable radiation threat 
X
Most of the cases are come in light after 
Acute radiation syndrome start to appear 
in exposed persons. So radiation mitigator 
will not be applicable in this scenario.  

Radiation therapeutics 
is the only choice of 
medical treatment of the 
radiation victims.
Note: X: Not applicable; : Applicable
table 3. Probable selection criteria of radiation countermeasure (protector, mitigator and therapeutic agents) applications in different 
emergency situations
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